Hyperactive Ras in developmental disorders and cancer - PubMed (original) (raw)

Review

doi: 10.1038/nrc2109.

Affiliations

• PMID: 17384584
• DOI: 10.1038/nrc2109

Review

Hyperactive Ras in developmental disorders and cancer

Suzanne Schubbert et al. Nat Rev Cancer. 2007 Apr.

Erratum in

• Nat Rev Cancer. 2007 Jul;7(7):563

Abstract

Ras genes are the most common targets for somatic gain-of-function mutations in human cancer. Recently, germline mutations that affect components of the Ras-Raf-mitogen-activated and extracellular-signal regulated kinase kinase (MEK)-extracellular signal-regulated kinase (ERK) pathway were shown to cause several developmental disorders, including Noonan, Costello and cardio-facio-cutaneous syndromes. Many of these mutant alleles encode proteins with aberrant biochemical and functional properties. Here we will discuss the implications of germline mutations in the Ras-Raf-MEK-ERK pathway for understanding normal developmental processes and cancer pathogenesis.

PubMed Disclaimer

Similar articles

• Noonan, Costello and cardio-facio-cutaneous syndromes: dysregulation of the Ras-MAPK pathway.
  Tidyman WE, Rauen KA. Tidyman WE, et al. Expert Rev Mol Med. 2008 Dec 9;10:e37. doi: 10.1017/S1462399408000902. Expert Rev Mol Med. 2008. PMID: 19063751 Review.
• Mutation analysis of the genes involved in the Ras-mitogen-activated protein kinase (MAPK) pathway in Korean patients with Noonan syndrome.
  Lee ST, Ki CS, Lee HJ. Lee ST, et al. Clin Genet. 2007 Aug;72(2):150-5. doi: 10.1111/j.1399-0004.2007.00839.x. Clin Genet. 2007. PMID: 17661820
• [Molecular genetic diagnostics in syndromes associated with the RAS/MAPK signalling pathway].
  Molven A, Søvik O, von der Lippe C, Steine SJ, Njølstad PR, Houge G, Prescott TE. Molven A, et al. Tidsskr Nor Laegeforen. 2009 Nov 19;129(22):2358-61. doi: 10.4045/tidsskr.09.0267. Tidsskr Nor Laegeforen. 2009. PMID: 19935936 Norwegian.
• The RAS/MAPK syndromes: novel roles of the RAS pathway in human genetic disorders.
  Aoki Y, Niihori T, Narumi Y, Kure S, Matsubara Y. Aoki Y, et al. Hum Mutat. 2008 Aug;29(8):992-1006. doi: 10.1002/humu.20748. Hum Mutat. 2008. PMID: 18470943 Review.

Cited by

• KRAS mutant colorectal tumors: past and present.
  Brand TM, Wheeler DL. Brand TM, et al. Small GTPases. 2012 Jan-Mar;3(1):34-9. doi: 10.4161/sgtp.18751. Small GTPases. 2012. PMID: 22714415 Free PMC article.
• ANT2 suppression by shRNA restores miR-636 expression, thereby downregulating Ras and inhibiting tumorigenesis of hepatocellular carcinoma.
  Jang JY, Lee YS, Jeon YK, Lee K, Jang JJ, Kim CW. Jang JY, et al. Exp Mol Med. 2013 Jan 10;45(1):e3. doi: 10.1038/emm.2013.1. Exp Mol Med. 2013. PMID: 23306701 Free PMC article.
• Regulation of the Small GTPase Ras and Its Relevance to Human Disease.
  Kulhanek KR, Roose JP, Rubio I. Kulhanek KR, et al. Methods Mol Biol. 2021;2262:19-43. doi: 10.1007/978-1-0716-1190-6_2. Methods Mol Biol. 2021. PMID: 33977469 Review.
• Molecular Mechanism of Autophagy and Its Regulation by Cannabinoids in Cancer.
  Lee XC, Werner E, Falasca M. Lee XC, et al. Cancers (Basel). 2021 Mar 10;13(6):1211. doi: 10.3390/cancers13061211. Cancers (Basel). 2021. PMID: 33802014 Free PMC article. Review.
• Deregulated ERK1/2 MAP kinase signaling promotes aneuploidy by a Fbxw7β-Aurora A pathway.
  Duhamel S, Girondel C, Dorn JF, Tanguay PL, Voisin L, Smits R, Maddox PS, Meloche S. Duhamel S, et al. Cell Cycle. 2016 Jun 17;15(12):1631-42. doi: 10.1080/15384101.2016.1183851. Epub 2016 May 6. Cell Cycle. 2016. PMID: 27152455 Free PMC article.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Nature Publishing Group

• Other Literature Sources

  • The Lens - Patent Citations Database

• Medical

  • MedlinePlus Health Information

• Research Materials

  • NCI CPTC Antibody Characterization Program

• Miscellaneous

  • NCI CPTAC Assay Portal